Mutual Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Mutual Advisors's REGN Position: Q2 2026 in Review
Mutual Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, buying an estimated $37.4K and bringing the position to 516 shares worth $322K. The position accounts for 0.01% of the portfolio, ranked #1149.
Mutual Advisors first reported a position in REGN in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.69M in Q3 2023. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Mutual Advisors held 516 shares of Regeneron Pharmaceuticals worth $322K as of Q2 2026.
- Mutual Advisors bought 55 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $37.4K.
- Regeneron Pharmaceuticals made up 0.01% of Mutual Advisors's portfolio in Q2 2026, its #1149 holding.
- Mutual Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
- Mutual Advisors's Regeneron Pharmaceuticals position peaked at $1.69M in Q3 2023.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.